180.53MMarket Cap-628P/E (TTM)
0.890High0.840Low1.58MVolume0.860Open0.845Pre Close1.36MTurnover0.84%Turnover RatioLossP/E (Static)208.22MShares1.48052wk High7.61P/B164.41MFloat Cap0.29152wk Low--Dividend TTM189.63MShs Float51.375Historical High--Div YieldTTM5.86%Amplitude0.291Historical Low0.859Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
Gene Editing Therapeutics Market Report 2024, Featuring Profiles of Key Players Allogene Therapeutics, CRISPR Therapeutics, Intellia Therapeutics, Sangamo Therapeutics and Vertex Pharmaceuticals - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Gene Editi
https://www.moomoo.com/t/news/post/43596799/BYnzVJBmba
Bought big Friday, looks like I made the right call. GLTA
No comment yet